ICLR Key Statistics, Chart & Performance
The current stock price of ICLR is 188.22 USD. In the past month the price increased by 3.82%. In the past year, price decreased by -13.75%.
ICLR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 27.08 | 227.87B | ||
| DHR | DANAHER CORP | 30.48 | 165.99B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 200.24 | 60.85B | ||
| A | AGILENT TECHNOLOGIES INC | 26.12 | 41.32B | ||
| IQV | IQVIA HOLDINGS INC | 20.91 | 41.42B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 35.02 | 29.93B | ||
| WAT | WATERS CORP | 31.23 | 23.61B | ||
| ILMN | ILLUMINA INC | 33.45 | 22.28B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 38.93 | 19.80B | ||
| MEDP | MEDPACE HOLDINGS INC | 41.96 | 16.90B | ||
| TEM | TEMPUS AI INC | N/A | 12.16B | ||
| RVTY | REVVITY INC | 21.23 | 11.53B |
Related stock screener links
About ICLR
Company Profile
ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. The company is headquartered in Dublin, Dublin and currently employs 39,800 full-time employees. The firm is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. The company offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The firm's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. The company also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Company Info
ICON PLC
South County Business Park, LEOPARDSTOWN, Dublin 18
DUBLIN DUBLIN 00000 IE
CEO: Steve Cutler
Employees: 39800
Phone: 35312912000
ICON PLC / ICLR FAQ
Can you describe the business of ICON PLC?
ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. The company is headquartered in Dublin, Dublin and currently employs 39,800 full-time employees. The firm is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. The company offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The firm's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. The company also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
What is the current price of ICLR stock?
The current stock price of ICLR is 188.22 USD. The price decreased by -7.24% in the last trading session.
Does ICON PLC pay dividends?
ICLR does not pay a dividend.
What is the ChartMill rating of ICON PLC stock?
ICLR has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Can you provide the sector and industry classification for ICON PLC?
ICON PLC (ICLR) operates in the Health Care sector and the Life Sciences Tools & Services industry.
Can you provide the growth outlook for ICON PLC?
The Revenue of ICON PLC (ICLR) is expected to decline by -2.44% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is ICON PLC worth?
ICON PLC (ICLR) has a market capitalization of 14.37B USD. This makes ICLR a Large Cap stock.
ICLR Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to ICLR. When comparing the yearly performance of all stocks, ICLR is a bad performer in the overall market: 76.22% of all stocks are doing better.
ICLR Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to ICLR. Both the profitability and the financial health of ICLR get a neutral evaluation. Nothing too spectacular is happening here.
ICLR Financial Highlights
Over the last trailing twelve months ICLR reported a non-GAAP Earnings per Share(EPS) of 13.19. The EPS decreased by -5.99% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.4% | ||
| ROA | 3.63% | ||
| ROE | 6.42% | ||
| Debt/Equity | 0.31 |
ICLR Forecast & Estimates
24 analysts have analysed ICLR and the average price target is 209.67 USD. This implies a price increase of 11.4% is expected in the next year compared to the current price of 188.22.
For the next year, analysts expect an EPS growth of -4.69% and a revenue growth -2.44% for ICLR